(Reuters) -James Hardie's Australia-listed shares fell more than 9% on Thursday to post their biggest two-session drop on record, after the fibre cement maker forecast 2026 earnings below analyst expectations, citing a weak North America market. The stock has declined nearly 35% over the past two days to A$28.98, shedding about A$9 billion ($5.78 billion) in market value in a selloff that shows broader investor frustration with Australia-listed companies failing to meet targets. The selloff began on Wednesday after the dual-listed company forecast adjusted operating earnings of $1.05 billion-$1.15 billion for fiscal 2026, missing a Visible Alpha consensus estimate of $1.23 billion. The midpoint of the forecast range also barely exceeded the $1.1 billion the company earned in fiscal 2025. Dublin-based James Hardie is grappling with a slowdown in its largest market North America, where weaker-than-expected single-family construction activity during the summer worsened demand for repair and remodelling work. Its North American fibre cement sales fell 12% to $641.8 million in the first quarter, while adjusted net income dropped to $126.9 million from $177.6 million a year earlier. The stock has lost nearly half its value this year, down 42.2% amid a slump in new single-family home sales in the U.S. due to higher borrowing costs and elevated inventory levels. Macquarie analysts flagged James Hardie's stretched balance sheet in a note, questioning the sustainability of its share buyback programme amid $5.1 billion in drawn debt pressuring finances. Jarden, however, said James Hardie should see a rebound given its relationships with builders, distributors, and contractors, while also highlighting potentially lower rates and a recovering U.S. construction market. Meanwhile, CSL shares tumbled nearly 20% in the two sessions through Wednesday, after the biotech firm ditched its key margin restoration goal for its blood plasma division, joining James Hardie in disappointing Australian investors with earnings-related setbacks. ($1 = 1.5574 Australian dollars) (Reporting by Nichiket Sunil in Bengaluru; Editing by Subhranshu Sahu and Sherry Jacob-Phillips)
James Hardie's Australia shares post biggest two-day drop on weak forecast
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...